Viscosupplementation is the treatment for Osteoarthritis which is the most common joint disease affecting the middle age to elderly section of the people. In this method, doses of hyaluronic acid are given through injections in affected joints in the synovial fluid. The course of treatment can be of single injection formulation or subsequent doses of multiple-injection (three-injection) formulation. Viscosupplementation helps in reducing pain and improving joint movements.
Currently the market for Hyaluronic Acid Viscosupplementation is estimated to be around $2 billion and is poised to grow in the future. The steady growth of 6.5% can be attributed to the rise in the geriatric ...view middle of the document...
This rise in the geriatric population across the globe has suggested the experts that the market shall grow at a CAGR 6.5% in the coming 5 years.
It is noted that the Hyaluronic Acid Viscosupplementation Market, Single Injections currently has fewer competitors as compared to the rest. Few key companies mentioned in the report would be:
• Fidia Farma USA Inc.
• Anika Therapeutics, Inc.
• Synvisc –One
• Zimmer, Inc.
Global Hyaluronic Acid Viscosupplementation – Market Landscape:
• Market Share Analysis
• Comparative Analysis
• Product Benchmarking
• End user profiling
• Patent Analysis
• Top 5 Financials Analysis
Global Hyaluronic Acid Viscosupplementation – Market Forces:
• Market Drivers
• Market Constraints
• Market Challenges
• Attractiveness of the Global Liquid Handling Systems Industry
Global Hyaluronic Acid Viscosupplementation Market – Strategic Analysis:
• Value Chain Analysis
• Pricing Analysis
• Opportunities Analysis
• Product/Market Life Cycle Analysis
• Suppliers and Distributors
Browse TOC, Customization Options Available @ http://industryarc.com/Report/5338/Hyaluronic-Acid-Viscosupplementation-Market-Research-Report.html
Get Sample Data of the report @...